These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 10451518
1. Prenatal diagnosis of sporadic neurofibromatosis type 1 (NF1) by RNA and DNA analysis of a splicing mutation. Ars E, Kruyer H, Gaona A, Serra E, Lázaro C, Estivill X. Prenat Diagn; 1999 Aug; 19(8):739-42. PubMed ID: 10451518 [Abstract] [Full Text] [Related]
2. Reproductive decisions after prenatal diagnosis in neurofibromatosis type 1: importance of genetic counseling. Terzi YK, Oguzkan-Balci S, Anlar B, Aysun S, Guran S, Ayter S. Genet Couns; 2009 Aug; 20(2):195-202. PubMed ID: 19650418 [Abstract] [Full Text] [Related]
3. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Messiaen LM, Callens T, Mortier G, Beysen D, Vandenbroucke I, Van Roy N, Speleman F, Paepe AD. Hum Mutat; 2000 Aug; 15(6):541-55. PubMed ID: 10862084 [Abstract] [Full Text] [Related]
4. Two independent mutations in a family with neurofibromatosis type 1 (NF1). Klose A, Peters H, Hoffmeyer S, Buske A, Lüder A, Hess D, Lehmann R, Nürnberg P, Tinschert S. Am J Med Genet; 1999 Mar 05; 83(1):6-12. PubMed ID: 10076878 [Abstract] [Full Text] [Related]
11. Molecular analysis of neurofibromatosis type 1 in Turkish families using polymorphic markers. Oğuzkan S, Cinbiş M, Ayter S, Anlar B, Aysun S. Turk J Pediatr; 2003 Jun 05; 45(3):192-7. PubMed ID: 14696795 [Abstract] [Full Text] [Related]
12. Tumor LOH analysis provides reliable linkage information for prenatal genetic testing of sporadic NF1 patients. Serra E, Pros E, García C, López E, Gili ML, Gómez C, Ravella A, Capellá G, Blanco I, Lázaro C. Genes Chromosomes Cancer; 2007 Sep 05; 46(9):820-7. PubMed ID: 17563086 [Abstract] [Full Text] [Related]
14. Antisense therapeutics for neurofibromatosis type 1 caused by deep intronic mutations. Pros E, Fernández-Rodríguez J, Canet B, Benito L, Sánchez A, Benavides A, Ramos FJ, López-Ariztegui MA, Capellá G, Blanco I, Serra E, Lázaro C. Hum Mutat; 2009 Mar 05; 30(3):454-62. PubMed ID: 19241459 [Abstract] [Full Text] [Related]
16. A novel mutation in the neurofibromatosis type 1 (NF1) gene promotes skipping of two exons by preventing exon definition. Fang LJ, Simard MJ, Vidaud D, Assouline B, Lemieux B, Vidaud M, Chabot B, Thirion JP. J Mol Biol; 2001 Apr 13; 307(5):1261-70. PubMed ID: 11292340 [Abstract] [Full Text] [Related]
17. Alport syndrome. Molecular genetic aspects. Hertz JM. Dan Med Bull; 2009 Aug 13; 56(3):105-52. PubMed ID: 19728970 [Abstract] [Full Text] [Related]
18. Neurofibromatosis type I (NFI) in Israeli families: linkage analysis as a diagnostic tool. Elyakim S, Lerer I, Zlotogora J, Sagi M, Gelman-Kohan Z, Merin S, Abeliovich D. Am J Med Genet; 1994 Dec 01; 53(4):325-34. PubMed ID: 7864041 [Abstract] [Full Text] [Related]
19. Neurofibromatosis type 1 due to germ-line mosaicism in a clinically normal father. Lázaro C, Ravella A, Gaona A, Volpini V, Estivill X. N Engl J Med; 1994 Nov 24; 331(21):1403-7. PubMed ID: 7969279 [Abstract] [Full Text] [Related]
20. Functional analysis of splicing mutations in exon 7 of NF1 gene. Bottillo I, De Luca A, Schirinzi A, Guida V, Torrente I, Calvieri S, Gervasini C, Larizza L, Pizzuti A, Dallapiccola B. BMC Med Genet; 2007 Feb 12; 8():4. PubMed ID: 17295913 [Abstract] [Full Text] [Related] Page: [Next] [New Search]